Fifth biannual report of the Cochrane Haematologic Malignancies Group--Focus on multiple myeloma.
Naumann
Frauke
F
Cochrane Haematological Malignancies Group, Cologne, Germany. frauke.naumann@uk-koeln.de
Weingart
Olaf
O
Kruse
Eva
E
Schulz
Holger
H
Bohlius
Julia
J
Hülsewede
Helge
H
Engert
Andreas
A
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D015337:Multicenter Studies as Topic; D009101:Multiple Myeloma / Q000188:drug therapy*; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic